Discover how inebilizumab reduces flares and improves remission rates in IgG4-related disease in this phase 3 clinical trial.

Muvalaplin shows promise in lowering lipoprotein(a) levels, which are genetically determined and confer cardiovascular risk ...

Cellular immunotherapy specialist Fate Therapeutics soared as much as 73%, and closed up 12.45 at $2.27 yesterday, after it ...

MOEA Big A+ program to accelerate AI innovation in medicine TAIPEI Nov 19 2024 PRNewswire -- Hon Hai Technology Group Foxconn TWSE2317 in partnership with two Taiwanese hospitals has been selected for ...

Starting your day with the right drink can kickstart your metabolism, improve digestion, and set the tone for healthy eating ...

Vasoactive Intestinal Peptide (VIP) is an intriguing neuropeptide with a wide range of potential biological impacts, primarily hypothesized in tissues, cells, and internal systems. Since its discovery ...

A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the ...

The community-focused well-being social club in Montclair will welcome Harvard stress expert and author Dr. Aditi Nerurkar on Thursday, Nov. 21.

Designed by Chengdu Borns, a medical robot company located in Chengdu Hi-Tech Industrial Development Zone, Sichuan province, the robot can accurately treat tumors while protecting the patient's organs ...

The method used by Dr Sam, a reputable physician with years of clinical experience ... Gut health and brain function are ...

More needs to be done to boost the research and development capabilities crucial to countries succeeding in manufacturing vaccines locally.

This clinical trial is made possible through Sen-Jam's novel and inclusive ... "This innovative solution is about promoting human health and maximizing productivity by supporting individuals who ...